While the PLCO Cancer Screening trial demonstrated no observed mortality benefit associated with screening for prostate cancer with prostate-specific antigen and rectal exam, the knowledge gained about prostate cancer and screening and resources developed in completing the trial make the trial a success.
Grubb RL, Pinsky P, Prorok PC, Andriole GL. Are you the author?
Department of Surgery, Washington University School of Medicine, St. Louis, MO, USA; Division of Cancer Prevention, National Cancer Institute, Bethesda, MD, USA.
Reference: Eur Urol. 2015 May 7. pii: S0302-2838(15)00328-0.